As Appraisal Fees Loom, NICE Says No To Industry Calls For Reform
A proposal by the UK's HTA body NICE to charge companies for technology appraisals has raised several issues, such as the need for reforms to the HTA process, ensuring independence and credibility of appraisals, greater accountability and transparency at NICE, and the impact of fees on bringing new medicines to market.
You may also be interested in...
England’s department of health is again consulting on plans to allow health technology appraisal body NICE to charge companies for conducting appraisals.
England’s department of health is again consulting on plans to allow the health technology appraisal body NICE to charge companies for conducting appraisals.
The UK National Institute for Health and Care Excellence will wait for the government to finalize its life sciences strategy before deciding on whether to go ahead with its plan to levy a fee for technology appraisals. Pharmaceutical and medtech companies say the delay by NICE will allow more time for their concerns over the proposal to be explored.